Giant Biogene Holding Co (HKSE:02367) Change In Inventory : HK$-19 Mil (TTM As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Giant Biogene Holding Co Change In Inventory?

Giant Biogene Holding Co's change in inventory for the quarter that ended in Dec. 2023 was HK$-16 Mil. It means Giant Biogene Holding Co's inventory increased by HK$16 Mil from Jun. 2023 to Dec. 2023 .

Giant Biogene Holding Co's change in inventory for the fiscal year that ended in Dec. 2023 was HK$-19 Mil. It means Giant Biogene Holding Co's inventory increased by HK$19 Mil from Dec. 2022 to Dec. 2023 .

Giant Biogene Holding Co's Total Inventories for the quarter that ended in Dec. 2023 was HK$219 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Giant Biogene Holding Co's Days Inventory for the quarter that ended in Dec. 2023 was 109.55.

Inventory Turnover measures how fast the company turns over its inventory within a year. Giant Biogene Holding Co's Inventory Turnover for the quarter that ended in Dec. 2023 was 1.67.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Giant Biogene Holding Co's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.10.

Giant Biogene Holding Co Change In Inventory Historical Data

The historical data trend for Giant Biogene Holding Co's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Giant Biogene Holding Co Change In Inventory Chart

Giant Biogene Holding Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Inventory

-10.68

-17.12

-30.13

-105.37

-19.43

Giant Biogene Holding Co Semi-Annual Data
	Dec19	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Inventory	Get a 7-Day Free Trial			-	-8.34	-97.42	-3.55	-15.88

Giant Biogene Holding Co Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-19 Mil.

Giant Biogene Holding Co (HKSE:02367) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Giant Biogene Holding Co's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	211.6085	/	352.53	*	365 / 2
	=	109.55

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Giant Biogene Holding Co's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	352.53	/	211.6085
	=	1.67

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Giant Biogene Holding Co's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	211.6085	/	2098.355
	=	0.10

Giant Biogene Holding Co Change In Inventory Related Terms

Thank you for viewing the detailed overview of Giant Biogene Holding Co's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Giant Biogene Holding Co (HKSE:02367) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Giant Biogene Holding Co Ltd (HKSE:02367) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1855, Shanglin Yuan 7th Road, Chang’an District, Shaanxi Province, Xi’an, CHN

Website

http://www.xajuzi.com

Giant Biogene Holding Co Ltd design, develop and manufacture professional skin treatment products with recombinant collagen as the key bioactive ingredient. The company also develops and manufactures rare ginsenosides technology-based functional foods. The company utilizes proprietary synthetic biology technology to develop and manufacture multiple types of recombinant collagen and rare ginsenosides in-house. Bioactive ingredients offer a wealth of beauty and health properties such as skin repair, anti-aging, whitening, moisturizing and immunity improvement with a broad range of applications in the beauty and health sectors.

Executives

Refulgence Holding Limited	2201 Interest of corporation controlled by you
Juzi Holding Co., Ltd	2101 Beneficial owner
Fan Daidi	2201 Interest of corporation controlled by you
Yan Jianya	2202 Interest of your spouse
Yi Fang Da Ji Jin Guan Li You Xian Gong Si	2102 Investment manager
Yan Jianya	2101 Beneficial owner
Fan Daidi
Trident Trust Company (b.v.i.) Limited	2301 Trustee

Giant Biogene Holding Co (HKSE:02367) Headlines

No Headlines